Xencor | XNCR - Loan Capital


Xencor reported $76.48M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Alnylam Pharmaceuticals USD 2.48B 1.44B Dec/2025
Amgen USD 50B 2.43B Dec/2025
Arrowhead Research USD 538.1M 323.22M Dec/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
Biogen USD 6.29B 1.4M Sep/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Cytokinetics USD 1.12B 957.23M Dec/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
J&J USD 39.44B 30M Dec/2025
Karyopharm Therapeutics USD -0.93 0.67 Dec/2024
MacroGenics USD 70M 256K Dec/2025
Merck USD 39.97B 6B Sep/2025
Novartis USD 29.59B 5.35B Dec/2025
Pfizer USD 57.41B 93M Sep/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Xencor USD 76.48M 11.29M Dec/2025